Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China
SYDNEY, Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, is sponsoring the Endpoints ASCO 22 “Accelerating clinical development in China and the US”. Register here https://asco22.endpts.com/TUESDAY, JUNE 711:00am – 11:45am ET (1:00 – 1:45 local time)Novotech
More
